摘要
目的:建立RP-HPLC法测定盐酸瑞伐拉赞片的含量和有关物质。方法:采用Inertsil ODS-SP C18(4.6 mm×150 mm,5μm)色谱柱,以0.01 mol·L^-1醋酸铵(醋酸调p H为5.0)-乙腈(40∶60)为流动相,流速1.0 m L·min^-1,检测波长266 nm,柱温35℃,进样量20μL。结果:盐酸瑞伐拉赞质量浓度在0.010~0.100 mg·m L^-1范围内线性相关系数为0.999 6,最低检出限为0.1μg·m L^-1,平均加样回收率(n=6)为99.3%(RSD=0.73%),重复性试验RSD为0.1%(n=6),12 h稳定性试验的RSD小于0.5%;瑞伐拉赞峰和相邻峰之间有良好的分离度。结论:该法经方法学验证,可用于盐酸瑞伐拉赞片的质量控制及有关物质测定。
Objective: To establish an RP- HPLC method for the determination of revaprazan hydrochloride content and related substance in its tables. Methods: The Inertsil ODS- SP C18( 4. 6 mm × 150 mm,5 μm) column was adopted with a mobile phase consisting of 0. 01 mol·L^-1ammonium acetate solution( adjusted to p H 5. 0 with acetic acid) and acetonitrile( 40∶ 60) at the flow rate of 1. 0 m L·min^-1. The detection wavelength was 266 nm,the column temperature was controlled at 35 ℃,and the inject volume was 20 μL. Results: The correlation coefficient of revaprazan hydrochloride was 0. 999 6 in the range of 0. 010-0. 100 mg·m L^-1,the LOD was 0. 1 μg·m L^-1,and the average recovery was 99. 3%( RSD = 0. 73 %,n = 6). The RSD of the repeatability test was 0. 1%( n = 6),the RSD of the 12 h stability was below 0. 5%; the satisfactory resolution between revaprazan peak and its adjacent peaks was achieved. Conclusion: The established method is proved to be applicable for quality control,and related substance determination of the revaprazan hydrochloride tablets.
出处
《药物分析杂志》
CAS
CSCD
北大核心
2015年第9期1660-1663,共4页
Chinese Journal of Pharmaceutical Analysis
关键词
盐酸瑞伐拉赞
反相高效液相色谱
杂质测定
方法验证
revaprazan hydrochloride
RP-HPLC
determination of related substances
methods validation